Year archive

Antengene Corporation Limited — 2026 filings

All 16 regulatory filings released by Antengene Corporation Limited (6996) in 2026, sourced directly from the official regulator.

16 Filings

2026 Period

2026 filings (16)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT CHINA IND APPROVAL FOR PIVOTAL PHASE III CLINCH-3 STUDY OF ATG-022 IN CLDN18.2+ ADVANCED GASTRIC/GEJ CANCER Regulatory Filings	2026-05-28	English
VOLUNTARY ANNOUNCEMENT APPOINTMENT OF CHIEF SCIENTIFIC OFFICER Board/Management Information	2026-05-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 Share Issue/Capital Change	2026-05-07	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2026-04-29	English
NOTICE OF THE ANNUAL GENERAL MEETING AGM Information	2026-04-29	English
(1) PROPOSALS FOR GENERAL MANDATES TO ISSUE AND RESELL SHARES AND TO REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) RE-APPOINTMENT OF THE AUDITOR; (4) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSO Proxy Solicitation & Information Statement	2026-04-29	English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2026-04-29	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-09	English
GRANT OF SHARE OPTIONS AND RSUS Remuneration Information	2026-04-07	English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY FOUNDER, CEO, CHAIRMAN AND OTHER MANAGEMENT Director's Dealing	2026-03-25	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 Annual Report FY 2025	2026-03-20	English
NOTICE OF DATE OF BOARD MEETING Report Publication Announcement	2026-03-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-05	English
INSIDE INFORMATION GLOBAL LICENSE AGREEMENT BETWEEN ANTENGENE AND UCB FOR ATG-201, A CD19/CD3 BISPECIFIC T-CELL ENGAGER FOR AUTOIMMUNE DISEASES Regulatory Filings	2026-03-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Regulatory Filings	2026-02-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Share Issue/Capital Change	2026-01-07	English